NEW YORK, Nov. 28 — Despite current economic conditions, Applied Biosystems remains optimistic about prospects for instrument sales, according to Stephen Lombardi, the company's vice president of applications and products. Speaking to a small early-morning audience of industry investors and analysts at the Robertson Stephens Medical Conference here on Wednesday, Lombardi said that NIH and pharma R&D spending continue to grow at rates in the range of 13 to 14 percent, and that’s good news for ABI. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.